Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person prostate carcinoma
| Class:Id | Disease:9701262 |
|---|---|
| _displayName | prostate carcinoma |
| _timestamp | 2020-09-25 14:49:23 |
| created | [InstanceEdit:9701267] Orlic-Milacic, Marija, 2020-09-25 |
| definition | A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells. |
| identifier | 10286 |
| name | prostate carcinoma |
| referenceDatabase | [ReferenceDatabase:1247631] DOID |
| synonym | cancer of prostate carcinoma of prostate |
| (disease) | [EntityWithAccessionedSequence:9703729] BRCA1 L668Pfs*33 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9703798] BRCA1 Y655Vfs*18 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9704499] PALB2 Q66* [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9704504] PALB2 W1038* [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9704572] PALB2 I265Tfs*5 [nucleoplasm] [Homo sapiens] [EntityWithAccessionedSequence:9704601] PALB2 S299Yfs*3 [nucleoplasm] [Homo sapiens] [ProteinDrug:9718359] buserelin [extracellular region] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by prostate carcinoma (9701262)
